Winners ECNP Citation Prize

2023
Kamilla Woznica Miskowiak et al.
Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables
Eur. Neuropsychopharmacol, 46, 2021, 39-48.

The paper was presented during the Top Paper Session at the 36^th ECNP Congress, 7-10 October 2023 in Barcelona, Spain, by Kamilla Woznica Miskowiak.
More info about this session can be found here.

2022
Martin Madsen et al.
A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding
Eur. Neuropsychopharmacol. 33, 2020, 71-80.

The paper was presented during the Top Paper Session at the 35^th ECNP Congress, 15-18 October 2022 in Vienna, Austria, by Martin Madsen.
More info about this session can be found here.

2021

• Christiaan H. Vinkers
• Therese van Amelsvoort
• Jonathan I. Bisson
• Igor Branchi
• John F. Cryan
• Katharina Domschke
• Oliver D. Howes
• Mirko Manchia
• Luisa Pinto
• Dominique de Quervain
• Mathias V. Schmid
• Nic J. A.van der Wee

'Stress resilience during the coronavirus pandemic'.
Click here to read the article on European Neuropsychopharmacology 35, 2020, 12-16.

2020

• Livia F. O’Leary
• Ebere S. Ogbonnaya
• Daniela Felice
• Brunno R. Levone
• Lorraine Conroy
• Patrick Fitzgerald
• Javier A.Bravo
• Paul Forsythe
• John Bienenstock
• Timothy G. Dinan
• John F. Cryan

'The vagus nerve modulates BDNF expression and neurogenesis in the hippocampus’.
Click here to read the article on the European Neuropsychopharmacology 28.2, February 2018, pp. 307-316 ().

2019

• Christian J. Bachmann
• Linda P. Wijlaars
• Luuk J. Kalverdijk
• Mehmet Burcue
• Gerd Glaeske
• Catharina C.M. Schuiling-Veninga
• Falk Hoffmann
• Lise Aagaard
• Julie M.Zito

‘Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012’.
Click here to read the article on the European Neuropsychopharmacology 27.5, May 2017, pp. 484-493 ().